Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 12

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 11,001–12,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
11001LY6D/PLA2G10 ratioGCST903153457.40e-05
11002CLEC1B/ITGB5 ratioGCST903140947.34e-05
11003Omega-3 fatty acids to total fatty acids percentageGCST905024667.33e-05
11004GGH/INHBC ratioGCST903149287.28e-05
11005PsoriasisFING000012227.27e-05
11006Peritonsillar abscessFING000011607.26e-05
11007ALB levelsGCST904751037.26e-05
11008CRTAM levelsGCST904688717.26e-05
11009Sphingomyelin_42:2_[M+H]1+ levelsGCST900604037.25e-05
11010Posterior thigh muscle fat infiltration percentageGCST902673557.23e-05
11011NFKB1 levelsGCST904700377.22e-05
11012EIF2AK2 levelsGCST904690917.22e-05
11013mean platelet volume (MPV, maximum, inv-norm transformed)GCST904755177.21e-05
11014DKK1/SDC4 ratioGCST903144797.20e-05
11015Glycoprotein acetyls levelsGCST904973207.20e-05
11016FKBP4/RWDD1 ratioGCST903148407.17e-05
11017Nontoxic multinodular goiter | endocrine/metabolicUKBB000005287.17e-05
11018Crohn's diseaseGCST0041327.15e-05
11019Migraine, single triptan purchase ok & required. ICD-code if available is includedFING000008247.12e-05
11020ALCAM/LRRC25 ratioGCST903132397.11e-05
11021CD69/PLXNB3 ratioGCST903138817.10e-05
11022SNAP23 levelsGCST904706907.05e-05
11023Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T488ECGU0004887.03e-05
11024Phospholipids to Total Lipids in Small HDL percentageGCST904995057.01e-05
11025CD84/SDC4 ratioGCST903139167.01e-05
11026ENG/TNFRSF10C ratioGCST903146507.00e-05
11027Cerebral amyloid angiopathyFING000002626.94e-05
11028ACRBP levelsGCST904682056.92e-05
11029Saturated fatty acids levelsGCST905026706.91e-05
11030F2R/PDGFB ratioGCST903147336.91e-05
11031MMP1 levelsGCST904699196.91e-05
11032CXCL5/PLXNA4 ratioGCST903143516.87e-05
11033Mean platelet volume during first trimester of pregnancyGCST903022296.86e-05
11034CLMP levelsGCST904687836.85e-05
11035NID1/SORT1 ratioGCST903155426.83e-05
11036CD244 levelsGCST902747716.81e-05
11037IRAK4 levelsGCST904696286.76e-05
11038CANT1 levelsGCST904685366.74e-05
11039SF3B4 levelsGCST904706096.73e-05
11040Carnitine levelsGCST902399916.72e-05
11041SPON1 levelsGCST904707316.69e-05
11042ASPSCR1 levelsGCST904683786.68e-05
11043CST3/EFEMP1 ratioGCST903142926.67e-05
11044GAL levelsGCST904693006.67e-05
11045HYOU1/TGFBR3 ratioGCST903151056.66e-05
11046Monocyte percentage of white cellsGCST900023946.64e-05
11047ITGA5/SELE ratioGCST903152056.64e-05
11048Mean platelet volume at deliveryGCST903022326.63e-05
11049FLT3LG levelsGCST902747916.63e-05
11050GGACT levelsGCST904693336.60e-05
11051ESYT2 levelsGCST904691566.59e-05
11052CCNE1 levelsGCST904685936.58e-05
11053CDNF levelsGCST904686866.56e-05
11054FGFBP2 levelsGCST904692316.55e-05
11055CMC1 levelsGCST904687946.55e-05
11056SFTPA1 levelsGCST904706126.54e-05
11057High light scatter reticulocyte countGCST0046116.54e-05
11058CD38/IL12A_IL12B ratioGCST903138086.54e-05
11059FAM3C/NECTIN2 ratioGCST903147816.49e-05
11060Platelet distribution width | Blood countUKBB000006486.48e-05
11061AFP levelsGCST902786156.46e-05
11062SERPINB1 levelsGCST904705896.41e-05
11063EREG/MPI ratioGCST903147056.40e-05
11064TREH levelsGCST904709596.36e-05
11065IDP dMRI TBSS L1 Cingulum cingulate gyrus RGCST900041096.36e-05
11066Omega-3 fatty acids to total fatty acids percentageGCST905024626.36e-05
11067Free cholesterol to total lipids ratio in large VLDLGCST900928736.33e-05
11068Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T109ECGA0001096.32e-05
11069EFNA1 levelsGCST904690806.30e-05
11070CD300C levelsGCST904686206.29e-05
11071MRC1 levelsGCST904699396.26e-05
11072ANGPTL3/TFPI ratioGCST903132706.23e-05
11073SKAP2 levelsGCST904706466.22e-05
11074KLRB1/KLRD1 ratioGCST903152606.22e-05
11075POF1B levelsGCST904702816.19e-05
11076SULT2A1 levelsGCST904707826.19e-05
11077EPHB6 levelsGCST904691336.17e-05
11078Heel bone mineral density (BMD) (right) | Bone-densitometry of heelUKBB000003146.16e-05
11079DAPP1/ITGB1BP2 ratioGCST903143886.14e-05
11080APOA1 levelsGCST904683316.14e-05
11081NRGN levelsGCST904700836.11e-05
11082Red cell distribution widthGCST900024046.10e-05
11083AXL/VCAM1 ratioGCST903134236.08e-05
11084LATS1 levelsGCST904697406.08e-05
11085CAPG levelsGCST904685376.05e-05
11086Free Cholesterol to Total Lipids in Small VLDL percentageGCST904998326.03e-05
11087MTIF3 levelsGCST904699576.02e-05
11088CD27/TNFRSF9 ratioGCST903137786.01e-05
11089Uterine fibroidsGCST900187146.00e-05
11090GMPR2 levelsGCST904693676.00e-05
11091YES1 levelsGCST904710885.99e-05
11092Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST904752755.99e-05
11093Seborrheic dermatitis (PheCode 690.1)GCST904761715.97e-05
11094RTN4IP1 levelsGCST904705075.95e-05
11095Mean arterial pressure, manual reading | Cardiovascular measurementUKBB000004415.92e-05
11096Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007915.92e-05
11097ALOX15B levelsGCST906175475.92e-05
11098Cholesterol in Small HDLGCST904993585.91e-05
11099DDR1/SFTPD ratioGCST903144435.89e-05
11100GM3 ganglioside (d18:1/24:0) levelsGCST900253405.89e-05
11101LAT levelsGCST904697415.85e-05
11102DKK1/VEGFA ratioGCST903144835.85e-05
11103CRELD2/TXNDC5 ratioGCST903142595.83e-05
11104Triglycerides to Total Lipids in Very Small VLDL percentageGCST905008865.81e-05
11105Bone density (confirmatory factor analysis Factor 19)GCST903093535.76e-05
11106DKK1/PDGFA ratioGCST903144755.75e-05
11107ITGA2 levelsGCST904696345.72e-05
11108TGFBR2/THBD ratioGCST903159165.72e-05
11109TINAGL1 levelsGCST904708735.71e-05
11110SCGB3A2 levelsGCST904705435.69e-05
11111Triacylglycerol_52:2_[M+NH4]1+ levelsGCST900605115.69e-05
11112PI16 levelsGCST904702295.69e-05
11113VWA1 levelsGCST904710615.68e-05
11114HHIP levelsGCST906170975.61e-05
11115white blood cell count (WBC, mean, inv-norm transformed)GCST904764545.60e-05
11116Athlete's foot (PheCode 110.12)GCST904755635.57e-05
11117HDL x depression interaction (2df test)GCST905706675.56e-05
11118Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024115.56e-05
11119Lysophosphatidylcholine (24:0) [sn2] levelsGCST900254265.54e-05
11120CCN2/SERPINB1 ratioGCST903137155.53e-05
11121SCG3 levelsGCST904705395.53e-05
11122red blood cell count (RBC, mean, inv-norm transformed)GCST904763475.52e-05
11123SOD2 levelsGCST904707055.51e-05
11124IL1R1 levelsGCST904695715.50e-05
11125ARHGEF12/IRAK4 ratioGCST903133505.48e-05
11126CD74/LILRB4 ratioGCST903138945.46e-05
11127TIMM8A levelsGCST904708685.46e-05
11128platelet count (minimum, inv-norm transformed)GCST904763025.44e-05
11129CD69/CDKN2D ratioGCST903138665.44e-05
11130Triglycerides in IDLGCST904976615.43e-05
11131TACSTD2 levelsGCST904707985.41e-05
11132CD300C/GOLM2 ratioGCST903137885.41e-05
11133CCN3/COL6A3 ratioGCST903137205.37e-05
11134ST6GAL1 levelsGCST904707535.36e-05
11135LAMA4/PDGFB ratioGCST903152735.35e-05
11136IFNG levelsGCST904695155.35e-05
11137Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004775.33e-05
11138FKBP5 levelsGCST904692445.32e-05
11139CD300C/MANSC1 ratioGCST903137915.32e-05
11140CXCL17 levelsGCST904689295.31e-05
11141ATF6 levelsGCST902408165.29e-05
11142Cholesterol in IDLGCST904974955.29e-05
11143CLEC1B/LBR ratioGCST903140955.29e-05
11144CILP levelsGCST904687545.27e-05
11145Monocyte countGCST900187475.27e-05
11146Platelet crit (UKB data field 30090)GCST904680965.27e-05
11147PSAP levelsGCST904703515.27e-05
11148SMOC1 levelsGCST904706825.27e-05
11149aparc-a2009s lh volume G-front-inf-OpercularGCST900029365.27e-05
11150DTI TBSS MD Superior corona radiata RGCST903845965.25e-05
11151Cholesterol levels in very large HDLGCST905003105.24e-05
11152B4GALT1 levelsGCST904684125.23e-05
11153PLIN3/TYMP ratioGCST903156785.22e-05
11154STAMBP/WWP2 ratioGCST903158885.22e-05
11155Concentration of small VLDL particlesGCST904998565.20e-05
11156IL12RB1 levelsGCST904695505.19e-05
11157PEAR1/SPINT2 ratioGCST903156445.19e-05
11158CDSN/KLK8 ratioGCST903139965.19e-05
11159GFER levelsGCST904693265.19e-05
11160CSF1/LTBR ratioGCST903142875.17e-05
11161PRELP levelsGCST904703215.13e-05
11162WASHC3 levelsGCST904710695.12e-05
11163Other contact dermatitisFING000009905.11e-05
11164Fracture of hand or wrist (PheCode 804)GCST904762815.11e-05
11165T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 107)GCST903206705.10e-05
11166AmygNuclei lh volume Medial-nucleusGCST900026535.08e-05
11167PLSCR3 levelsGCST904702615.07e-05
11168RAB27B levelsGCST904704055.06e-05
11169Erythematosquamous dermatosis (PheCode 690)GCST904761705.05e-05
11170TNFRSF1B levelsGCST900120265.05e-05
11171CDCP1/MSR1 ratioGCST903139385.05e-05
11172BACH1/NFATC1 ratioGCST903134445.04e-05
11173Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levelsGCST900604235.02e-05
11174CD69 levelsGCST904686435.02e-05
11175SBSN levelsGCST904705315.01e-05
11176EPHA4 levelsGCST904691315.00e-05
11177Mosaic chromosomal alteration of the Y chromosomeGCST901652894.97e-05
11178TNFAIP8L2 levelsGCST904708974.96e-05
11179CD300E levelsGCST904686214.95e-05
11180Severe autoimmune type 2 diabetesGCST900264124.92e-05
11181Glycoprotein acetyls levels (UKB data field 23480)GCST902695774.90e-05
11182CCL11/CCL13 ratioGCST903136714.88e-05
11183PTGES2 levelsGCST904703694.86e-05
11184Monocyte percentage (UKB data field 30190)GCST904680914.83e-05
11185FUT3_FUT5/LILRA2 ratioGCST903148894.83e-05
11186Triacylglycerol_56:6_[M+NH4]1+ levelsGCST900605534.80e-05
11187IL16/NADK ratioGCST903151524.79e-05
11188ALKBH3 levelsGCST906190954.79e-05
11189Fluid intelligence score decline (log-difference score)GCST905658524.75e-05
11190Current employment status - Doing unpaid or voluntary work | EmploymentUKBB000001574.74e-05
11191Total bilirubin levelsGCST902786434.72e-05
11192White blood cell countGCST900023754.71e-05
11193SEC31A levelsGCST904705634.70e-05
11194Linoleic acid to total fatty acids percentageGCST905023214.69e-05
11195Gastric cancerGCST900186294.67e-05
11196SCARA5 levelsGCST904705334.65e-05
11197Crohn's diseaseGCST904467934.63e-05
11198CTSF levelsGCST904689124.63e-05
11199ADAMTS16 levelsGCST904682244.61e-05
11200NRP2 levelsGCST904700864.58e-05
11201X-25371 levelsGCST902006564.58e-05
11202Peptic ulcer diseaseGCST902709264.57e-05
11203EREG/HBEGF ratioGCST903147024.57e-05
11204TGFBI/VASN ratioGCST903159154.56e-05
11205TREML1 levelsGCST904709614.52e-05
11206Serum urea levelsGCST900259914.49e-05
11207Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)GCST902697294.48e-05
11208TNFRSF13B levelsGCST904709054.48e-05
11209Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T138ECGU0001384.45e-05
11210SLC9A3R1 levelsGCST904706654.43e-05
11211GASK1A levelsGCST904693064.43e-05
11212PDGFC levelsGCST904701904.41e-05
11213Seronegative rheumatoid arthritisFING000012964.41e-05
11214NOTCH3 levelsGCST904700674.41e-05
11215T1 FreeSurfer a2009s lh S postcentral areaGCST903847344.40e-05
112163-(4-hydroxyphenyl)lactate levelsGCST902435754.39e-05
11217GALNT10/TNFSF12 ratioGCST903149164.33e-05
11218CD46/NID1 ratioGCST903138334.33e-05
11219CD244 levelsGCST904686114.32e-05
11220GART levelsGCST904693034.30e-05
11221Disorders of skin appendagesFING000004604.28e-05
11222Total cholesterol levelsGCST902786444.27e-05
11223MARS1 levelsGCST904698624.27e-05
11224Fibromuscular dysplasiaGCST900266124.27e-05
11225AmygNuclei lh volume Accessory-Basal-nucleusGCST900026504.27e-05
11226CD28 levelsGCST904686164.26e-05
11227CD160/CXCL16 ratioGCST903137284.26e-05
11228MANSC1 levelsGCST904698474.26e-05
11229Acetoacetate levelsGCST900928044.25e-05
11230Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T109ECGU0001094.24e-05
11231PLB1 levelsGCST904702534.23e-05
11232Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T113ECGU0001134.23e-05
11233Clonal hematopoiesis (overall)GCST904353534.21e-05
11234ALCAM/MSR1 ratioGCST903132404.19e-05
11235CETN2 levelsGCST904687214.18e-05
11236Diseases of external earFING000004244.18e-05
11237high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753564.18e-05
11238ELN levelsGCST904691034.17e-05
11239CLEC4G/KDR ratioGCST903141184.17e-05
11240Right ventricular stroke volumeGCST902681224.13e-05
11241Stroke, excluding SAHFING000013374.13e-05
11242DTI TBSS MD Posterior corona radiata LGCST903845994.11e-05
11243PECAM1/SOD2 ratioGCST903156474.11e-05
11244Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heelUKBB000003234.11e-05
11245Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heelUKBB000003174.11e-05
11246DAB2 levelsGCST904689424.11e-05
11247GCC1 levelsGCST904693154.08e-05
11248Biliary cirrhosis, NASFING000002134.07e-05
11249GPC1 levelsGCST904693864.04e-05
11250rfMRI connectivity (ICA100 edge 383)GCST900052364.03e-05
11251F9/RARRES2 ratioGCST903147494.01e-05
11252Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)GCST902695494.00e-05
11253Total Dihexosylceramide levelsGCST900251934.00e-05
11254CRADD levelsGCST904688543.99e-05
11255CA12 levelsGCST904685073.98e-05
11256PILRB levelsGCST904702373.97e-05
11257NFATC1 levelsGCST904700333.96e-05
11258NAAA/SMPD1 ratioGCST903155103.96e-05
11259Omega-3 fatty acid levelsGCST905024403.94e-05
11260monocyte (fraction, maximum, inv-norm transformed)GCST904755083.94e-05
11261PPME1/PSMD9 ratioGCST903157053.93e-05
11262EREG levelsGCST904691453.92e-05
11263aseg lh volume HippocampusGCST900026243.92e-05
11264CST1 levelsGCST904688933.91e-05
11265EIF4G1/FOXO1 ratioGCST903146343.91e-05
11266SORCS2 levelsGCST904707083.89e-05
11267SERPINB9 levelsGCST904705933.89e-05
11268SIRPB1 levelsGCST904706403.89e-05
11269CD48 levelsGCST904256763.88e-05
11270CD74/DLL1 ratioGCST903138913.86e-05
11271ANPEP/DPP4 ratioGCST903132733.86e-05
11272BSG/TNFRSF4 ratioGCST903135363.86e-05
11273Abdominal hernia (PheCode 550)GCST904760593.85e-05
11274BCR/NFATC1 ratioGCST903134963.85e-05
11275CHCHD10 levelsGCST904687383.85e-05
11276ELAC1 levelsGCST904691013.84e-05
11277Charcot footFING000002683.84e-05
11278C8 Carnitine levels in chronic kidney diseaseGCST902576803.83e-05
11279GFRA1 levelsGCST904693283.83e-05
11280CRKL levelsGCST904688673.82e-05
11281Alzheimer's disease or family history of Alzheimer's diseaseGCST900128773.82e-05
11282PSRC1/SORT1 ratioGCST903157423.82e-05
11283SERPINB1/SERPINB9 ratioGCST903158273.81e-05
11284CCL23 levelsGCST904685753.80e-05
11285Heel bone mineral density (BMD) (left) | Bone-densitometry of heelUKBB000003133.79e-05
11286RAP1A levelsGCST904704253.79e-05
11287LILRB1 levelsGCST904697763.79e-05
11288LTBP2 levelsGCST904698143.79e-05
11289CD209 levelsGCST904686083.76e-05
11290Right-hemisphere visual network to pallidum white-matter structural connectivityGCST903027843.76e-05
11291Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classifiedFING000004323.76e-05
11292STX8 levelsGCST904707763.76e-05
11293CX3CL1/PODXL2 ratioGCST903143263.74e-05
11294Blood clot / pulmonary embolism / deep vein thrombosis (DVT)GCST904752093.70e-05
11295aseg rh intensity CaudateGCST900037833.70e-05
11296DSG2 levelsGCST904690423.69e-05
11297MILR1 levelsGCST904699073.66e-05
11298ANGPTL4 levelsGCST904683053.65e-05
11299S100P levelsGCST904705203.65e-05
11300ADH4/KYNU ratioGCST903131933.63e-05
11301SIGLEC6 levelsGCST904706343.63e-05
11302REST UKBBICA NODEamps25 0003GCST903854863.62e-05
11303FSHB levelsGCST904692703.62e-05
11304NID1 levelsGCST904700473.62e-05
11305wg lh intensity-contrast temporalpoleGCST900038243.61e-05
11306DKK1/VASH1 ratioGCST903144823.56e-05
11307Crohn's disease of large intestineFING000003683.56e-05
11308CRKL/MANF ratioGCST903142693.54e-05
11309Non-allergic asthma (mode) (more control exclusions)FING000008693.53e-05
11310Reticulocyte countGCST900024053.53e-05
11311CD69/CLEC1B ratioGCST903138693.53e-05
11312Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levelsGCST900603753.53e-05
11313HPCAL1 levelsGCST904694713.53e-05
11314SPRY2 levelsGCST904707383.52e-05
11315ADGRE1 levelsGCST904682363.50e-05
11316SLAMF8 levelsGCST904706523.50e-05
11317MANSC1/PODXL2 ratioGCST903153713.49e-05
11318PLG levelsGCST904702573.49e-05
11319GP1BA/HBEGF ratioGCST903149563.48e-05
11320MMP9/OLR1 ratioGCST903154673.48e-05
11321IL17D levelsGCST904695603.47e-05
11322MSR1/TNFRSF21 ratioGCST903154943.46e-05
11323Phospholipids in very large HDL (UKB data field 23553)GCST902696503.46e-05
11324CLEC4C levelsGCST904687723.46e-05
11325FOLH1 levelsGCST904271923.46e-05
11326SLC27A4 levelsGCST904706573.45e-05
11327CLUL1 levelsGCST904687923.42e-05
11328Omega-3 fatty acid levelsGCST905024363.42e-05
11329CD6 levelsGCST904686443.40e-05
11330IL12B levelsGCST904695493.39e-05
11331CD58/SIRPB1 ratioGCST903138553.37e-05
11332Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024143.37e-05
11333Severity of induration at injection site at the injection site after COVID-19 booster vaccinationGCST904544093.34e-05
11334End-diastolic bi-ventricular shape (principal component 2)GCST904484813.31e-05
11335GIMAP7 levelsGCST904693453.31e-05
11336OSM levelsGCST904701333.31e-05
11337KLK10 levelsGCST904696963.29e-05
11338BDNF levelsGCST904684373.28e-05
11339GALNT5 levelsGCST904692983.28e-05
11340COX5B levelsGCST904688343.27e-05
11341Phospholipids to Total Lipids in Small VLDL percentageGCST904999023.25e-05
11342DIABLO/VSIR ratioGCST903144703.25e-05
11343TGFBR2/TNFRSF1A ratioGCST903159183.24e-05
11344LRP11 levelsGCST904697963.24e-05
11345Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025553.23e-05
11346HTRA2 levelsGCST904694943.23e-05
11347LBR/MAD1L1 ratioGCST903152953.22e-05
11348Platelet countGCST900023583.20e-05
11349ENO1 levelsGCST904691093.20e-05
11350DCTN1/TRIAP1 ratioGCST903144343.20e-05
11351BSG/IL12A_IL12B ratioGCST903135323.19e-05
11352DNER levelsGCST904690193.17e-05
11353Omega-3 fatty acid levelsGCST905024233.16e-05
11354TFPI2 levelsGCST904708383.14e-05
11355GRAP2 levelsGCST904693993.13e-05
11356VLDL cholesterol levelsGCST905001963.13e-05
11357TNN levelsGCST904709273.13e-05
11358CLEC4D levelsGCST904687733.13e-05
11359DBI levelsGCST904689493.11e-05
11360LEG1 levelsGCST904697533.11e-05
11361Total fatty acid levelsGCST905027103.10e-05
11362FBLN2 levelsGCST904691933.09e-05
11363CHRDL1/SMOC2 ratioGCST903140623.08e-05
11364Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heelUKBB000003223.07e-05
11365Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heelUKBB000003163.07e-05
11366T1 FreeSurfer BA rh BA4p exvivo areaGCST903855523.06e-05
11367ATRAID levelsGCST904683993.06e-05
11368GATD3 levelsGCST904693093.06e-05
11369Alkenylphosphatidylcholine (P-16:0/16:0) levelsGCST900255633.06e-05
11370X-17357 levelsGCST902005503.03e-05
11371CLEC1B/VTA1 ratioGCST903141073.03e-05
11372Ratio of saturated fatty acids to total fatty acidsGCST900929813.02e-05
11373ICA1/YTHDF3 ratioGCST903151133.02e-05
11374C1QA levelsGCST904684853.02e-05
11375CD46/NECTIN2 ratioGCST903138323.01e-05
11376Red cell distribution widthGCST900023693.00e-05
11377white blood cell count (WBC, minimum, inv-norm transformed)GCST904764573.00e-05
11378CD69/NFATC1 ratioGCST903138792.99e-05
11379CD22/FCER2 ratioGCST903137562.96e-05
11380ANXA4/LACTB2 ratioGCST903132932.96e-05
11381Phospholipids in small HDLGCST904994832.95e-05
11382PLCB2 levelsGCST904702552.95e-05
11383Gastro-oesophageal reflux diseaseFING000005642.95e-05
11384BTC levelsGCST904684762.94e-05
11385Phospholipids to total lipids in very large HDL percentage (UKB data field 23629)GCST902697262.93e-05
11386DSC2/SPINT1 ratioGCST903145572.93e-05
11387Rotator cuff injuryGCST900447002.92e-05
11388T1 FreeSurfer DK lh precuneus volumeGCST903856802.92e-05
11389DDHD2 levelsGCST904689682.91e-05
11390CPXM1 levelsGCST904688492.90e-05
11391SarcoidosisGCST905034832.90e-05
11392AppendectomyFING000001042.89e-05
11393EDAR/SPARC ratioGCST903145882.89e-05
11394CDC37 levelsGCST904686652.88e-05
11395rfMRI amplitudes (ICA100 node 15)GCST900046032.87e-05
11396PTPRZ1 levelsGCST904703882.86e-05
11397PIGR levelsGCST904702322.84e-05
11398GFRA3 levelsGCST904693302.83e-05
11399STK4 levelsGCST904707672.83e-05
11400PTX3 levelsGCST904703922.83e-05
11401T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71)GCST903206342.83e-05
11402rfMRI connectivity ICA-features 3GCST900063412.82e-05
11403KAZN levelsGCST904696662.81e-05
11404IDP T1 FAST ROIs R ventral striatumGCST900025602.81e-05
11405MAMDC2 levelsGCST904698412.81e-05
11406neutrophil (absolute count, mean, inv-norm transformed)GCST904755292.81e-05
11407LRG1 levelsGCST904697932.79e-05
11408PLXDC2 levelsGCST904702642.79e-05
11409CRELD2/F2R ratioGCST903142542.79e-05
11410DTI TBSS FA Posterior thalamic radiation RGCST903844082.79e-05
11411HBEGF/PDGFB ratioGCST903150342.78e-05
11412DKK1/VTA1 ratioGCST903144852.78e-05
11413Gestational [pregnancy-induced] hypertensionFING000005712.78e-05
11414CDON levelsGCST904686872.77e-05
11415KIFBP/LYN ratioGCST903152462.77e-05
11416SDC1 levelsGCST904705582.77e-05
11417Anterior thigh muscle fat infiltration percentageGCST902673512.77e-05
11418IGF1R levelsGCST904695242.75e-05
11419Conductive hearing loss (PheCode 389.2)GCST904759122.75e-05
11420ICAM3/NOTCH1 ratioGCST903151222.75e-05
11421APRT levelsGCST904683452.74e-05
11422Triglycerides to Total Lipids in Small LDL percentageGCST904997262.74e-05
11423IMMT levelsGCST904696092.73e-05
11424ABHD14B/APRT ratioGCST903131372.70e-05
11425GGCT levelsGCST904693342.70e-05
11426WNT9A levelsGCST904710792.68e-05
11427SUGT1/TBL1X ratioGCST903158972.67e-05
11428Skin luminanceGCST903202572.66e-05
11429ARSA levelsGCST904683682.65e-05
11430X-21736 levelsGCST902005842.63e-05
11431PDCD1LG2 levelsGCST904701802.63e-05
11432DBNL/DNAJA2 ratioGCST903144152.62e-05
11433Dermatophytosis (PheCode 110.1)GCST904755612.62e-05
11434ADAM8 levelsGCST904682202.61e-05
11435MAX levelsGCST904698672.60e-05
11436TFRC levelsGCST904708402.60e-05
11437CSF3 levelsGCST904688862.57e-05
11438PsoriasisGCST900190162.57e-05
11439C9 levelsGCST904685052.55e-05
11440IL12B levelsGCST902747982.55e-05
11441lymphocyte (fraction, maximum, inv-norm transformed)GCST904754322.54e-05
11442ABL1/PDLIM7 ratioGCST903131502.54e-05
11443TMPRSS5 levelsGCST904708932.53e-05
11444PTPN1/SCAMP3 ratioGCST903157432.52e-05
11445Ganglion cell inner plexiform layer (GCIPL) thicknessGCST900142672.49e-05
11446CLEC1A/GPR37 ratioGCST903140842.49e-05
11447CD244/TREML2 ratioGCST903137672.49e-05
11448PRDX3 levelsGCST904703172.49e-05
11449LY96/ST6GAL1 ratioGCST903153482.48e-05
11450ESM1 levelsGCST904691532.48e-05
11451Omega-6 fatty acids to total fatty acids percentageGCST905025452.47e-05
11452TXNDC15 levelsGCST904709902.45e-05
11453EBAG9/MITD1 ratioGCST903145662.45e-05
11454Triglycerides in HDLGCST904974642.44e-05
11455AmygNuclei rh volume Accessory-Basal-nucleusGCST900026602.44e-05
11456DNMBP/TJAP1 ratioGCST903145212.43e-05
11457Monounsaturated fatty acids to total fatty acids percentageGCST905023842.43e-05
11458NOTCH1/SEMA7A ratioGCST903155452.42e-05
11459FCAR levelsGCST904691972.41e-05
11460GRN levelsGCST904694042.40e-05
11461Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010912.37e-05
11462CLSTN2/MATN2 ratioGCST903141432.37e-05
11463LGALS9 levelsGCST904697652.37e-05
11464DLL1/EFEMP1 ratioGCST903144942.37e-05
11465DKK1/PTPN6 ratioGCST903144782.37e-05
11466Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027482.33e-05
11467COMP/ICAM1 ratioGCST903141892.33e-05
11468GM3 ganglioside (d18:1/24:0) levelsGCST900247292.33e-05
11469OtosclerosisFING000011312.32e-05
11470Monocyte percentage of white cellsGCST0046092.31e-05
11471SPINT1 levelsGCST904707272.31e-05
11472MOG levelsGCST904699292.30e-05
11473Nontoxic goitre/thyroid noduleFING000008872.30e-05
11474Hepatomegaly (PheCode 573.3)GCST904760922.30e-05
11475PAG1 levelsGCST904701472.29e-05
11476DRG2 levelsGCST904690392.29e-05
11477SDC4/SEMA4D ratioGCST903158182.29e-05
11478neutrophil (fraction, minimum, inv-norm transformed)GCST904755412.28e-05
11479Right ventricular ejection fractionGCST901345912.28e-05
11480SNAP29/VEGFC ratioGCST903158622.26e-05
11481Blood cell traits latent factor 8 (white cell)GCST905592502.26e-05
11482CCL28 levelsGCST904685802.26e-05
11483KLK7 levelsGCST904697062.25e-05
11484CRTAM/KLRD1 ratioGCST903142772.24e-05
11485Heel broadband ultrasound attenuation (right) | Bone-densitometry of heelUKBB000003202.24e-05
11486Linoleic acid levelsGCST905020122.24e-05
11487Aspartate aminotransferase levelsGCST900187242.23e-05
11488CDH5/ENG ratioGCST903139542.23e-05
11489CKAP4/PGF ratioGCST903140752.23e-05
11490NPDC1/PTGDS ratioGCST903155492.23e-05
11491CD200R1 levelsGCST904686052.23e-05
11492MSR1 levelsGCST904699502.22e-05
11493PGLYRP1 levelsGCST904702192.22e-05
11494ANXA4 levelsGCST904683192.21e-05
11495Low hand grip strength (60 years and older) (EWGSOP)GCST900075272.21e-05
11496CSF2RB levelsGCST904688832.20e-05
11497Migraine with auraFING000008192.20e-05
11498White blood cell countGCST900259852.20e-05
11499FABP1/SULT2A1 ratioGCST903147552.20e-05
11500Malignant melanoma, excluding all cancers (controls excluding all cancers)FING000007502.18e-05
11501NOTCH3/PTPRS ratioGCST903155472.18e-05
11502MIF levelsGCST904699062.17e-05
11503FST/FSTL3 ratioGCST903148822.17e-05
11504DSC2/EFEMP1 ratioGCST903145552.17e-05
11505CD5/TNFRSF9 ratioGCST903138622.17e-05
11506FLT4/ICAM2 ratioGCST903148602.17e-05
11507KLK11 levelsGCST904696972.16e-05
11508Lymphocyte percentage (UKB data field 30180)GCST904680832.16e-05
11509Red blood cell erythrocyte count (UKB data field 30010)GCST904680982.16e-05
11510CD63 levelsGCST904686422.16e-05
11511Aspartate aminotransferase levelsGCST902786182.15e-05
11512Coronary angioplastyFING000003572.14e-05
11513IL12A_IL12B/LAG3 ratioGCST903151472.13e-05
11514PDLIM7/PLA2G4A ratioGCST903156372.12e-05
11515CXCL6 levelsGCST904689332.12e-05
11516IGSF8/NECTIN2 ratioGCST903151402.11e-05
11517FCRL6/GZMA ratioGCST903148062.11e-05
11518CD48 levelsGCST904686352.10e-05
11519Mean platelet volumeGCST0045992.10e-05
11520TPSAB1 levelsGCST904709512.10e-05
11521ITGA5/VCAM1 ratioGCST903152062.09e-05
11522ERBB2 levelsGCST904691392.09e-05
11523TIMP1 levelsGCST904708692.09e-05
11524Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST903093692.08e-05
11525Red blood cell countGCST900024032.07e-05
11526BACH1/PDLIM7 ratioGCST903134452.07e-05
11527DBI/EDAR ratioGCST903144082.06e-05
11528lymphocyte (fraction, mean, inv-norm transformed)GCST904754352.06e-05
11529Left ventricular wall thickness (mean)GCST904352642.05e-05
11530Left ventricular wall thickness (maximal)GCST904352632.05e-05
11531GALNT10 levelsGCST904692952.05e-05
11532TNFRSF8/TNFRSF9 ratioGCST903159402.02e-05
11533PDLIM7/TBC1D23 ratioGCST903156402.02e-05
11534Phospholipids to Total Lipids in Medium VLDL percentageGCST904990432.01e-05
11535Free Cholesterol in VLDLGCST905002212.01e-05
11536FCRL5 levelsGCST904692082.00e-05
11537ANPEP/CXADR ratioGCST903132722.00e-05
11538EDAR/TACC3 ratioGCST903145891.99e-05
11539IRAK1/NFATC1 ratioGCST903151941.99e-05
11540Average diameter for HDL particles (UKB data field 23433)GCST902695301.99e-05
11541CD40/IGSF8 ratioGCST903138151.99e-05
11542TMEM25 levelsGCST904708881.98e-05
11543Bone marrow fat fraction of thoracic vertebra 12GCST906523841.97e-05
11544CA4/TNFSF12 ratioGCST903135891.97e-05
11545T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 40)GCST903208591.97e-05
11546Breast cancerGCST900185791.97e-05
11547Cholesterol_[M+H-H2O]1+ levelsGCST900601331.97e-05
11548Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING000013881.96e-05
11549PolyarthropathiesFING000011801.95e-05
11550LGALS8 levelsGCST904697641.95e-05
11551Triacylglycerol_58:7_[M+NH4]1+ levelsGCST900605641.94e-05
11552PDGFB/PRKAR1A ratioGCST903156241.94e-05
11553CLEC14A/PIK3IP1 ratioGCST903140801.93e-05
11554STK24 levelsGCST904707661.93e-05
11555Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004281.92e-05
11556NECTIN2/SPON2 ratioGCST903155301.92e-05
11557Phosphate | Blood biochemistryUKBB000006441.92e-05
11558MMP9/PLTP ratioGCST903154711.92e-05
11559triglyceride (minimum, inv-norm transformed)GCST904764391.92e-05
11560CNST/ITGB1BP2 ratioGCST903141581.92e-05
11561SMAD5 levelsGCST904706781.90e-05
11562LILRA2 levelsGCST904697711.90e-05
11563PLXNA4/SRPK2 ratioGCST903156881.90e-05
11564Crohn's diseaseGCST904753181.89e-05
11565VSIG10 levelsGCST904710501.87e-05
11566Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025661.87e-05
11567CLEC1B/VSIR ratioGCST903141061.87e-05
11568CA6/DNER ratioGCST903135941.86e-05
11569Osteoporosis (PheCode 743.1)GCST904762591.86e-05
11570White blood cell countGCST900187581.85e-05
11571MARCO levelsGCST904698611.85e-05
11572RAD23B levelsGCST904704181.84e-05
11573Concentration of VLDL particlesGCST905002461.84e-05
11574DNAJB1/EIF4B ratioGCST903145081.83e-05
11575COMP/DPP4 ratioGCST903141881.83e-05
11576Monounsaturated fatty acid levelsGCST905023581.83e-05
11577VASP levelsGCST904710281.83e-05
11578CRH levelsGCST904688621.82e-05
11579Phospholipids in large VLDLGCST904982431.81e-05
11580BTN2A1 levelsGCST904684801.81e-05
11581Saturated fatty acids levelsGCST905026581.81e-05
11582AmygNuclei rh volume Whole-amygdalaGCST900026671.80e-05
11583THPO levelsGCST904708571.80e-05
11584CR1 levelsGCST904688511.80e-05
11585RTBDN levelsGCST904705051.79e-05
11586F11R/GP1BA ratioGCST903147221.78e-05
11587Phospholipids in large HDL (UKB data field 23560)GCST902696571.78e-05
11588EDAR/TMSB10 ratioGCST903145901.75e-05
11589PFKFB2 levelsGCST904702151.74e-05
11590Neutrophil countGCST900259771.74e-05
11591AXL/MSR1 ratioGCST903134221.73e-05
11592CRIM1 levelsGCST904688631.73e-05
11593Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T110ECGU0001101.70e-05
11594NUDT5/TXNRD1 ratioGCST903155821.70e-05
11595CTF1 levelsGCST904689011.70e-05
11596MANSC1/PODXL ratioGCST903153721.70e-05
11597PlateletcritGCST900024001.68e-05
11598MDGA1 levelsGCST904698751.67e-05
11599Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)FING000007661.66e-05
11600ASS1 levelsGCST904683801.66e-05
11601Osteoporosis NOS (PheCode 743.11)GCST904762601.66e-05
11602neutrophil (fraction, maximum, inv-norm transformed)GCST904755351.66e-05
11603Alanine levels (UKB data field 23460)GCST902695571.64e-05
11604IDP dMRI TBSS MO Pontine crossing tractGCST900039531.63e-05
11605CD22/CD79B ratioGCST903137551.62e-05
11606Heel broadband ultrasound attenuation (left) | Bone-densitometry of heelUKBB000003191.62e-05
11607GPR37 levelsGCST904693971.62e-05
11608Total protein levelsGCST904681051.61e-05
11609Mean platelet thrombocyte volume (UKB data field 30100)GCST904680871.61e-05
11610DTI TBSS L3 Anterior corona radiata LGCST903845471.61e-05
11611ADGRE2 levelsGCST904682371.61e-05
11612AXL/CD163 ratioGCST903134181.59e-05
11613Lymphocyte percentage of white cellsGCST0046321.59e-05
11614Monocyte countGCST0046251.58e-05
11615Hereditary corneal dystrophiesFING000006111.58e-05
11616DTI TBSS L1 External capsule LGCST903844611.58e-05
11617CD163/MARCO ratioGCST903137371.57e-05
11618ENO3 levelsGCST904691111.57e-05
11619CD40/CRELD2 ratioGCST903138111.56e-05
11620EDAR/SNAP23 ratioGCST903145871.56e-05
11621PPBP levelsGCST904702891.56e-05
11622TEK levelsGCST904708291.55e-05
11623high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)GCST904753481.54e-05
11624KYNU/SCLY ratioGCST903152651.54e-05
11625CD58/MEGF10 ratioGCST903138531.54e-05
11626white blood cell count (WBC, maximum, inv-norm transformed)GCST904764511.53e-05
11627neutrophil (absolute count, maximum, inv-norm transformed)GCST904755261.53e-05
11628TNFRSF10C levelsGCST904709011.53e-05
11629Total protein levelsUKBB000008261.53e-05
11630SORT1 levelsGCST904707101.52e-05
11631IMPA1 levelsGCST904696101.50e-05
11632Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009581.50e-05
11633TriglyceridesGCST0007581.49e-05
11634VNN2 levelsGCST904710441.48e-05
11635DTI TBSS MD FornixGCST903845771.48e-05
11636Plasma N-acetyltaurine levels in chronic kidney diseaseGCST902656001.48e-05
11637VSIG4 levelsGCST904710521.47e-05
11638Monounsaturated fatty acids to total fatty acids percentageGCST904991091.46e-05
11639PPP1R2/TACC3 ratioGCST903157191.46e-05
11640Total Phosphatidylcholine levelsGCST900252041.45e-05
11641MAVS/TBL1X ratioGCST903153991.45e-05
11642PLXNB3 levelsGCST904702671.45e-05
11643AAMDC levelsGCST904681861.44e-05
116441-ribosyl-imidazoleacetate levelsGCST901998151.44e-05
11645Total testosterone levelsGCST900121121.43e-05
11646SLAMF7/TXNDC15 ratioGCST903158501.42e-05
11647SIRT2 levelsGCST904706421.42e-05
11648Concentration of medium VLDL particlesGCST904990161.41e-05
11649Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021661.41e-05
11650CEACAM19 levelsGCST904686911.41e-05
11651PSG1 levelsGCST904703531.41e-05
11652IL6R levelsGCST904696021.41e-05
11653CLEC14A levelsGCST904687661.41e-05
11654LGALS8/SOD2 ratioGCST903153201.40e-05
11655Deep biteFING000003801.40e-05
11656rfMRI connectivity (ICA100 edge 1099)GCST900059521.40e-05
11657red blood cell count (RBC, mean, inv-norm transformed)GCST904763491.40e-05
11658NELL2 levelsGCST904700271.39e-05
11659MYOC/NOTCH3 ratioGCST903155071.38e-05
11660MZB1 levelsGCST904699871.38e-05
11661ITGA11 levelsGCST904696331.38e-05
11662Cheesecake likingGCST900947301.38e-05
11663Bifidobacterium catenulatum abundance in stoolGCST900322241.38e-05
11664ALCAM/CNTN1 ratioGCST903132351.38e-05
11665DDR1 levelsGCST904689701.37e-05
11666MGMT levelsGCST904699021.36e-05
11667CPA4 levelsGCST904688381.36e-05
11668CRYGD levelsGCST904688761.35e-05
11669FCRL5/ICAM3 ratioGCST903148021.35e-05
11670Lung cancerGCST900186551.35e-05
11671Glutamine levelsGCST904972821.34e-05
11672Basophil countGCST900259971.34e-05
11673Allergic asthma (mode)FING000000661.33e-05
11674PPP3R1 levelsGCST904703071.32e-05
11675PCDH9 levelsGCST904701721.32e-05
11676FCGR2B levelsGCST904692011.32e-05
11677BACH1/HEXIM1 ratioGCST903134401.32e-05
11678SCGB1A1 levelsGCST904705401.31e-05
11679CLEC6A levelsGCST904687771.30e-05
11680DTI TBSS L3 FornixGCST903845291.30e-05
11681NUCB2 levelsGCST904701011.29e-05
11682BST2/CEACAM1 ratioGCST903135371.29e-05
11683ADA levelsGCST904682311.29e-05
11684Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005651.28e-05
11685KLK8/NECTIN4 ratioGCST903152581.28e-05
11686PF4 levelsGCST904702111.28e-05
11687CCL15/CCL23 ratioGCST903136811.28e-05
11688PTPRH levelsGCST904703821.27e-05
11689HSD17B14 levelsGCST904694831.27e-05
11690PLA2G4A levelsGCST904702481.27e-05
11691CCDC80/CCL27 ratioGCST903136691.26e-05
11692CD83/HAVCR2 ratioGCST903139041.26e-05
11693PTPRM levelsGCST904703841.26e-05
11694ITGB7 levelsGCST904696471.26e-05
11695Cardiovascular diseases (excluding rheumatic etc)FING000002551.26e-05
11696CEP20 levelsGCST904687121.25e-05
11697IGDCC4 levelsGCST904695231.25e-05
11698Hypertensive heart disease (PheCode 401.21)GCST904759251.25e-05
11699CD163/SIGLEC1 ratioGCST903137391.23e-05
11700FUT8/PDGFA ratioGCST903148901.23e-05
11701MXRA8 levelsGCST904699681.23e-05
11702GP6/HPCAL1 ratioGCST903149631.23e-05
11703Diseases of male genital organsFING000004261.22e-05
11704T1 FreeSurfer BA rh BA3b exvivo areaGCST903855501.21e-05
11705ITGB1BP2 levelsGCST900120581.21e-05
11706CD99/CD99L2 ratioGCST903139231.21e-05
11707CD163/FOLR2 ratioGCST903137341.21e-05
11708CD27/FCRL5 ratioGCST903137721.19e-05
11709XCL1 levelsGCST904710811.19e-05
11710VCAM1 levelsGCST904710311.17e-05
11711BGN levelsGCST904684411.16e-05
11712Glycoprotein acetyls levelsGCST900928211.16e-05
11713lymphocyte (fraction, minimum, inv-norm transformed)GCST904754381.14e-05
11714T1 FreeSurfer BA rh BA2 exvivo volumeGCST903855761.14e-05
11715ITGB1/VASN ratioGCST903152321.13e-05
11716ENO2/PLXNA4 ratioGCST903146651.12e-05
11717DTI autoptx L3 ifo l tractGCST903852051.12e-05
11718DNAJA2/PLXNA4 ratioGCST903145041.11e-05
11719FXN/TRIAP1 ratioGCST903148991.10e-05
11720BACH1/CNST ratioGCST903134361.10e-05
11721CD84/DKK1 ratioGCST903139111.09e-05
11722NELL2/SEZ6L ratioGCST903155361.08e-05
11723Free cholesterol in very large VLDLGCST905005751.07e-05
11724Basophil countGCST900023791.06e-05
11725Cholesteryl Esters in Small HDLGCST904993821.06e-05
11726Cholesterol in Small HDLGCST904993481.06e-05
11727Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009201.06e-05
11728FCGR2A levelsGCST904692001.06e-05
11729ICAM3/TNFRSF13B ratioGCST903151241.05e-05
11730red blood cell count (RBC, maximum, inv-norm transformed)GCST904763451.05e-05
11731DAB2/VASH1 ratioGCST903143691.05e-05
11732WFDC12 levelsGCST904710731.05e-05
11733Lymphocyte percentage of white cellsGCST900023891.05e-05
11734SHBG levelsGCST905033151.04e-05
11735CCN3/PGF ratioGCST903137221.04e-05
11736FGF21 levelsGCST904692221.03e-05
11737CPXM1/SPARC ratioGCST903142221.03e-05
11738Gastric ulcerGCST902709271.02e-05
11739LCN2 levelsGCST904697471.01e-05
11740DTI autoptx FA fmi tractGCST903851231.01e-05
11741SELPLG levelsGCST904705681.01e-05
11742TIMP4 levelsGCST904708721.01e-05
11743STAMBP levelsGCST904707561.00e-05
11744neutrophil (fraction, mean, inv-norm transformed)GCST904755389.90e-06
11745Congestive heart failureGCST904752009.87e-06
11746SERPINB1/TMSB10 ratioGCST903158309.84e-06
11747CD93 levelsGCST904686569.77e-06
11748HMBS/PKLR ratioGCST903150639.75e-06
11749CD300C/HAVCR2 ratioGCST903137899.74e-06
11750Gout, strict definitionFING000005889.71e-06
11751C1S levelsGCST904684949.71e-06
11752CALCOCO1/MAP3K5 ratioGCST903136059.66e-06
11753VTA1 levelsGCST904710589.66e-06
11754Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB000004469.65e-06
11755HDLBP levelsGCST900875339.59e-06
11756N-acetyl-1-methylhistidine levelsGCST902006909.59e-06
11757Triglycerides to Total Lipids in Small VLDL percentageGCST904999349.58e-06
11758aseg global volume WM-hypointensitiesGCST900026049.56e-06
11759Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114ECGU0001149.50e-06
11760Urine 3-hydroxyindolin-2-one sulfate levels in chronic kidney diseaseGCST902645089.49e-06
11761Triglycerides in medium LDLGCST904988649.38e-06
11762CLU levelsGCST904687939.33e-06
11763Fractured/broken bones in last 5 years | Medical conditionsUKBB000002589.28e-06
11764HPCAL1/MPIG6B ratioGCST903150739.24e-06
11765SIGLEC8 levelsGCST904706369.11e-06
11766ALB levelsGCST904751009.09e-06
11767SCARB2 levelsGCST904705359.08e-06
11768IL7 levelsGCST904696069.04e-06
11769Bone marrow fat fraction of thoracic vertebra 8GCST906523808.96e-06
11770Mean platelet volume during second trimester of pregnancyGCST903022308.93e-06
11771LRRC37A2 levelsGCST904698028.91e-06
11772SERPINE1/VASH1 ratioGCST903158368.91e-06
11773FOLR1 levelsGCST904692598.82e-06
11774NADK/S100A11 ratioGCST903155138.73e-06
11775ITGB6 levelsGCST904696468.72e-06
11776CD163 levelsGCST904686008.72e-06
11777Cerebrospinal fluid 5-methylthioadenosine (MTA) levelsGCST903182168.70e-06
11778CXCL3 levelsGCST904689318.66e-06
11779high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753528.63e-06
11780Clonal haematopoiesis of indeterminate potential (with or without mosaic chromosomal alteration)GCST901652678.51e-06
11781Degree of unsaturationGCST905027528.51e-06
11782BCAM/CDH5 ratioGCST903134698.50e-06
11783Other Crohn's diseaseFING000009928.50e-06
11784VSNL1 levelsGCST904710548.49e-06
11785Concentration of very large VLDL particlesGCST905006288.42e-06
11786CACNB3 levelsGCST904685238.41e-06
11787wg rh intensity-contrast entorhinalGCST900038328.39e-06
11788T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 73)GCST903206368.37e-06
11789BMP10 levelsGCST904684528.36e-06
11790AGR3 levelsGCST904682548.35e-06
11791PDGFB/PTPN6 ratioGCST903156258.34e-06
11792Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T221ECGU0002218.29e-06
11793FYB1 levelsGCST904692848.28e-06
11794Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025928.23e-06
11795BCAM/SEMA7A ratioGCST903134768.22e-06
11796Clonal haematopoiesis of indeterminate potential (ASXL1 mutation)GCST901652598.12e-06
11797RNF146 levelsGCST904214798.03e-06
11798MANF/NCK2 ratioGCST903153597.99e-06
11799Free cholesterol in small LDLGCST904996207.99e-06
11800NADK/PXN ratioGCST903155127.95e-06
11801Lymphocyte percentage | Blood countUKBB000004127.94e-06
11802CRTAC1 levelsGCST904688707.90e-06
11803JAM2 levelsGCST904696597.81e-06
11804CD69/SNAP29 ratioGCST903138877.77e-06
11805Nonalcoholic fatty liver diseaseGCST900910337.73e-06
11806ARHGEF12/DECR1 ratioGCST903133497.72e-06
11807ICAM3 levelsGCST904695007.64e-06
11808TMEM106A levelsGCST904708867.56e-06
11809GPI levelsGCST904693917.53e-06
11810Height decline (log-difference score)GCST905658537.51e-06
11811LTBR/TNFRSF14 ratioGCST903153407.47e-06
11812EFNA4 levelsGCST904690817.42e-06
11813Total lipids in medium VLDLGCST904990047.40e-06
11814DAPP1 levelsGCST904689467.35e-06
11815LILRB4 levelsGCST904697787.32e-06
11816ADM levelsGCST904682467.29e-06
11817COL1A1 levelsGCST904688137.22e-06
11818Retinal nerve fibre layer (RNFL) thicknessGCST900142667.17e-06
11819IGFBP3 levelsGCST904695297.17e-06
11820FUS levelsGCST904692787.16e-06
11821LRP11/NECTIN2 ratioGCST903153297.14e-06
11822High density lipoprotein cholesterol levelsGCST902786357.13e-06
11823Polyunsaturated fatty acids to total fatty acids percentageGCST905026337.12e-06
11824TRIAP1 levelsGCST904709637.04e-06
11825ACAN levelsGCST904681967.00e-06
11826ALB levelsGCST904971016.94e-06
11827SUSD5 levelsGCST904707896.93e-06
11828Generalized epilepsyFING000005676.92e-06
11829CD72 levelsGCST904686466.85e-06
11830CTHRC1 levelsGCST904689026.84e-06
11831SCAMP3/VPS53 ratioGCST903158076.84e-06
11832Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491ECGU0004916.80e-06
11833CGREF1 levelsGCST904687356.80e-06
11834Aspartate aminotransferase levels (UKB data field 30650)GCST904680636.76e-06
11835triglyceride (mean, inv-norm transformed)GCST904764356.73e-06
11836GAL/PM20D1 ratioGCST903149176.72e-06
11837MMP9/OSM ratioGCST903154686.69e-06
11838CX3CL1/LAYN ratioGCST903143256.64e-06
11839MAN2B2 levelsGCST904698446.62e-06
11840Alanine aminotransferase levelsGCST900187236.59e-06
11841CLEC1B/TXNDC5 ratioGCST903141056.57e-06
11842KLRB1 levelsGCST904697096.55e-06
11843Ascites (non malignant) (PheCode 572)GCST904760906.44e-06
11844VEGFC levelsGCST904710366.39e-06
11845GPC5 levelsGCST904693876.39e-06
11846HemoglobinGCST902786316.37e-06
11847PHACTR2 levelsGCST904702246.36e-06
11848PODXL2 levelsGCST904702796.35e-06
11849QPCT levelsGCST904704016.35e-06
11850Total lipids in small VLDLGCST904998406.30e-06
11851IL12A or IL12B levelsGCST904695486.30e-06
11852Saturated fatty acids levelsGCST904999506.28e-06
11853Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115ECGU0001156.27e-06
11854CCL5 levelsGCST904685846.23e-06
11855DTI autoptx FA ilf l tractGCST903851266.20e-06
11856CPVL levelsGCST904688486.19e-06
11857APRT/CD63 ratioGCST903133346.09e-06
11858MPIG6B/SUSD1 ratioGCST903154876.07e-06
11859SUSD2 levelsGCST904707876.03e-06
11860XRCC4 levelsGCST904710855.95e-06
11861Intracerebral hemorrhageGCST900186505.88e-06
11862Triglycerides to Total Lipids in Medium VLDL percentageGCST904990735.86e-06
11863AmygNuclei lh volume Cortical-nucleusGCST900026545.84e-06
11864CXCL1 levelsGCST904689305.77e-06
11865MEGF10 levelsGCST904698825.75e-06
11866CEACAM5 levelsGCST904686965.73e-06
11867Triacylglycerol_49:3_[M+NH4]1+ levelsGCST900604435.72e-06
11868KIRREL2 levelsGCST904696905.72e-06
11869Polyunsaturated fatty acids to total fatty acids percentageGCST905026445.70e-06
11870RARRES2/TFPI ratioGCST903157605.69e-06
11871Follicular cysts of skin and subcutaneous tissueFING000005475.64e-06
11872FAM20A levelsGCST904691855.54e-06
11873CNST levelsGCST904688015.53e-06
11874Omega-6 fatty acids to total fatty acids percentageGCST905025405.49e-06
11875F2R/MPIG6B ratioGCST903147325.49e-06
11876ITGB1/ITGB2 ratioGCST903152255.49e-06
11877APP/PPP1R12A ratioGCST903133305.48e-06
11878Endometriosis of rectovaginal septum and vaginaFING000005035.47e-06
11879Phospholipids to Total Lipids in Large VLDL percentageGCST904982585.43e-06
11880CHIT1 levelsGCST904687445.41e-06
11881CLPS/PRSS2 ratioGCST903141415.40e-06
11882CRTAM/LY9 ratioGCST903142785.40e-06
11883PRSS27 levelsGCST904703425.40e-06
11884ACVRL1/SCARB2 ratioGCST903131575.38e-06
11885EGF levelsGCST904690865.36e-06
11886NELL1 levelsGCST904700265.35e-06
11887Total lipid levels in chylomicrons and extremely large VLDLGCST905009945.34e-06
11888B3GNT7 levelsGCST904684115.31e-06
11889PDGFB/SDC4 ratioGCST903156265.29e-06
11890CASP8/PRDX6 ratioGCST903136555.24e-06
11891ENO2/FXYD5 ratioGCST903146595.23e-06
11892SIGLEC9 levelsGCST904706375.23e-06
11893CCL5/TFPI ratioGCST903137085.23e-06
11894EDAR/LAT2 ratioGCST903145825.19e-06
11895CLEC1B levelsGCST904687685.17e-06
11896CLEC1A levelsGCST904687675.09e-06
11897Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10)GCST900426785.08e-06
11898HCLS1 levelsGCST904694375.08e-06
11899Diseases of liverFING000004255.07e-06
11900LRRN1 levelsGCST904698065.03e-06
11901SFTPA2 levelsGCST904706135.00e-06
11902Squamous cell carcinoma (MTAG)GCST901374124.99e-06
11903RNF5 levelsGCST904704884.96e-06
11904PSME2/RBKS ratioGCST903157374.95e-06
11905CCL17 levelsGCST904685694.94e-06
11906TNFRSF1A/TNFRSF1B ratioGCST903159374.92e-06
11907ADH4/SCLY ratioGCST903131954.73e-06
11908Glycoprotein acetyls levelsGCST904973284.68e-06
11909Concentration of large VLDL particlesGCST904982264.67e-06
11910Right ventricular peak ejection rateGCST902681204.67e-06
11911Phospholipids in VLDLGCST905002664.63e-06
11912APLP1 levelsGCST904683304.60e-06
11913PKD1 levelsGCST904702404.59e-06
11914Bone marrow fat fraction of thoracic vertebra 11GCST906523834.57e-06
11915ADIPOQ levelsGCST904682454.56e-06
11916Triglycerides in large LDLGCST904980764.53e-06
11917ERBIN levelsGCST904691424.51e-06
11918Mean platelet volume during the postpartum periodGCST903022334.51e-06
11919PPP1R14D levelsGCST904703034.47e-06
11920ITGAV levelsGCST904696394.47e-06
11921CRADD/EREG ratioGCST903142364.44e-06
11922Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB000004294.43e-06
11923AmygNuclei rh volume Medial-nucleusGCST900026634.42e-06
11924DKK3 levelsGCST904689984.42e-06
11925PODXL levelsGCST904702804.39e-06
11926ROBO2/SCARF2 ratioGCST903157844.37e-06
11927Total triglycerides levelsGCST905001404.33e-06
11928AXIN1/CALCOCO1 ratioGCST903134024.31e-06
11929Basophil percentage of white cellsGCST900023804.29e-06
11930FIS1/PDGFB ratioGCST903148304.26e-06
11931ICAM1/REG1A ratioGCST903151144.25e-06
11932Basophill percentage | Blood countUKBB000000874.21e-06
11933Disorders of orbitFING000004494.20e-06
11934Pneumoconiosis due to other inorganic dustsFING000011734.20e-06
11935Total lipids in large VLDLGCST904982074.10e-06
11936NOTCH1 levelsGCST904700654.09e-06
11937SarcoidosisFING000012754.09e-06
11938CD48/SLAMF7 ratioGCST903138424.05e-06
11939LAT2/SERPINB1 ratioGCST903152794.02e-06
11940BCAN levelsGCST904684264.02e-06
11941FOXO1/NFATC1 ratioGCST903148734.01e-06
11942Free Cholesterol to Total Lipids in Large VLDL percentageGCST904981994.00e-06
11943Aspartate aminotransferase | Blood biochemistryUKBB000000524.00e-06
11944Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004453.99e-06
11945CD84/GP1BA ratioGCST903139133.96e-06
11946FLT3 levelsGCST904692513.93e-06
11947ADGRG1 levelsGCST904682403.91e-06
11948X-11786--methylcysteine levelsGCST902436543.90e-06
11949BTN2A1/SIGLEC1 ratioGCST903135483.89e-06
11950MET/PTPRF ratioGCST903154353.89e-06
11951Free cholesterol in medium LDLGCST904987743.88e-06
11952Cholesterol to Total Lipids in Large VLDL percentageGCST904981303.87e-06
11953SCARF1/SUSD1 ratioGCST903158113.84e-06
11954Mucosal proctocolitisFING000008413.82e-06
11955T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST903209203.78e-06
11956CCL14 levelsGCST904685663.78e-06
11957Omega-6 fatty acids levelsGCST904991703.76e-06
11958NFX1 levelsGCST904700413.70e-06
11959KLK6 levelsGCST900120083.69e-06
11960CSTB levelsGCST900120063.64e-06
11961Leucine levelsGCST902434053.61e-06
11962Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009833.58e-06
11963TACC3 levelsGCST904707973.55e-06
11964FCRL5/MZB1 ratioGCST903148043.54e-06
11965Regional enteritis (PheCode 555.1)GCST904760663.50e-06
11966CXCL16/NOTCH1 ratioGCST903143393.48e-06
11967Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025813.47e-06
11968LAG3 levelsGCST904697273.45e-06
11969Neutrophil percentage of white cellsGCST0046333.43e-06
11970POSTN levelsGCST904702883.41e-06
11971Neonatal jaundice (paternal effect)GCST904351473.40e-06
11972ICAM1 levelsGCST904694983.38e-06
11973Diacylglycerol_38:5_[M+H-H2O]1+ levelsGCST900602003.38e-06
11974RWDD1/SUMF2 ratioGCST903157953.37e-06
11975Alzheimer's disease (MTAG)GCST904490583.34e-06
11976Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005423.34e-06
11977APRT/EREG ratioGCST903133353.33e-06
11978Left hippocampal volumeGCST902679523.32e-06
11979SLC39A5 levelsGCST904706613.26e-06
11980Nontoxic nodular goiter | endocrine/metabolicUKBB000005293.24e-06
11981AIFM1 levelsGCST904682683.15e-06
11982FCER1A levelsGCST904691983.15e-06
11983MED18/TBL1X ratioGCST903154153.14e-06
11984Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006553.13e-06
11985CDKN1A/TACC3 ratioGCST903139753.09e-06
11986TNFRSF4/TNFRSF8 ratioGCST903159383.06e-06
11987CD69/SCARF1 ratioGCST903138853.04e-06
11988LGALS8/VWF ratioGCST903153223.03e-06
11989Dermatophytosis / Dermatomycosis (PheCode 110)GCST904755603.02e-06
11990CCL22 levelsGCST904685743.01e-06
11991Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T112ECGU0001123.01e-06
11992Reticulocyte countGCST900259722.99e-06
11993CD163/ICAM1 ratioGCST903137352.95e-06
11994NECTIN2/TNFRSF14 ratioGCST903155312.91e-06
11995Takes medication for congestive heart failure?GCST904752012.90e-06
11996CXCL5 levelsGCST904689322.90e-06
11997HLA-E levelsGCST904694592.88e-06
11998CD200 levelsGCST904686062.88e-06
11999Omega-3 fatty acid levelsGCST905024222.84e-06
12000Omega-6 fatty acid levelsGCST905021032.83e-06